Wang W.-L.Chang I.-W.Chang C.-Y.Lin J.-T.Mo L.-R.HSIU-PO WANGLee C.-T.2021-01-152021-01-1520140016-5107https://www.scopus.com/inward/record.uri?eid=2-s2.0-84920025423&doi=10.1016%2fj.gie.2014.07.025&partnerID=40&md5=d7b05da6f5ba0121f7e3a6cfb2be8ba2https://scholars.lib.ntu.edu.tw/handle/123456789/540982[SDGs]SDG3antibiotic agent; esomeprazole; narcotic agent; narcotic analgesic agent; paracetamol; sucralfate; coloring agent; iodide; Lugol's solution; ablation catheter; adult; antibiotic therapy; argon plasma coagulation; Article; balloon catheter; balloon dilatation; cancer patient; cancer radiotherapy; cancer size; cancer surgery; clinical article; clinical effectiveness; esophageal squamous cell carcinoma; esophagus hemorrhage; esophagus resection; esophagus stenosis; female; fever; follow up; hematoma; human; human tissue; male; middle aged; multimodality cancer therapy; outcome assessment; patient safety; pilot study; prospective study; radiofrequency ablation; radiofrequency ablation device; sore throat; thorax pain; treatment duration; tumor biopsy; ultralong extensive flat esophageal squamous cell carcinoma; adverse effects; Carcinoma, Squamous Cell; catheter ablation; devices; diagnostic use; Esophageal Neoplasms; esophagoscopy; pathology; procedures; treatment outcome; Carcinoma, Squamous Cell; Catheter Ablation; Coloring Agents; Esophageal Neoplasms; Esophagoscopy; Female; Humans; Iodides; Male; Middle Aged; Pilot Projects; Prospective Studies; Treatment Outcomejournal article10.1016/j.gie.2014.07.025252571272-s2.0-84920025423